Impact of model for end-stage liver disease (MELD) scoring system on pathological findings at and after liver transplantation

Liver Transplantation

Volumn 12, Issue 6, 2006, Pages 958-965

  Khettry, Urmila ^a,c   Azabdaftari, Gissou ^b   Simpson, Mary Ann ^a   Pomfret, Elizabeth A ^a,c   Pomposelli, James J ^a,c   Lewis, W David ^a,c   Jenkins, Roger L ^a,c   Gordon, Fredric D ^a,c  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CHOLESTASIS; CONTROLLED STUDY; CORRELATION FUNCTION; CRYOSURGERY; DISEASE SEVERITY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER NODULE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PATIENT SELECTION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX;

EID: 33745510423     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20728     Document Type: Article

References (22)

1. Freeman Jr RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R, UNOS/ OPTN Liver and Intestine Transplantation Committee. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:7-15.
2. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96.
3. Freeman Jr RB, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving towards evidence based transplantation policy. Liver Transpl 2002;8:851-858.
4. Brown Jr RS, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002;8:278-284.
5. Yu AS, Ahmed A, Keeff EB. Liver transplantation: evolving patient selection criteria. Can J Gastroenterol 2001;15:729-738.
6. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
7. Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003;9:12-18.
8. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003;52:134-139.
9. Edwards EB, Harper AM. Application of a continuous disease severity score to the OPTN liver waiting list. Clin Transpl 2001;19-24.
10. Cheng SJ, Freeman Jr RB, Wong JB. Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl 2002;8:323-328.
11. Llado L, Figueras J, Memba R, Xiol X, Baliellas C, Vazquez S, et al. Is MELD really the definitive score for liver allocation? Liver Transpl 2002;8:795-798.
12. Freeman RB. Liver allocation for HCC: a moving target. Liver Transpl 2004;10:49-51.
13. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-1417.
14. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004;10:36-41.
15. Lee DH, Son JH, Kim TW. New scoring systems for severity outcomes of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of end-stage liver disease (MELD) score. Taehan Kan Hakhoe Chi 2003;9:167-179.
16. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003;9:473-476.
17. Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, et al. Model for end-stage liver disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl 2003;9:737-740.
18. Onaca NN, Levy MF, Netto GJ, Thomas MJ, Sanchez EQ, Chinnakotla S, et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 2003;3:626-630.
19. Nissenbaum M, Chedid A, Mendenhall C, Gartside P, VA Cooperative Study Group 119. Prognostic significance of cholestatic alcoholic hepatitis. Dig Dis Sci 1990;35:891-896.
20. Harrison RF, Davies MH, Goldin RD, Hubscher SG. Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis. Histopathology 1993;23:21-28.
21. 1, mediates hepatocyte mito-inhibition during the evolution of cirrhosis. Hepatology 2005;41:1262-1271.
22. Hayashi PT, Trotter JF, Forman L, Kugelmas M, Steinberg T, Russ P, et al. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadaveric liver allocation in the era of MELD. Liver Transpl 2004;10:42-48.